Diagnosis of psoriasis: tests and instrumental methods

The physician's primary goal is to confirm that the typical plaques, scalp lesions, nail changes, and subjective symptoms are consistent with psoriasis and not with dermatoses that mimic it. In most cases, the diagnosis is established clinically based on a combination of symptoms and locations, without the need for laboratory markers. A skin biopsy is required for atypical manifestations, unusual locations, in children, in combination with eczema or seborrheic dermatitis, and before escalating therapy if the diagnosis is in doubt. [1]

It's important to remember the limited value of classic "textbook signs." Auspitz's sign describes pinpoint blood drops after scraping off scales, but it is neither sensitive nor specific and therefore cannot be used as a sole criterion. Koebner's sign helps explain new elements at injury sites, but it also occurs in other dermatoses and is also not used as a standalone diagnostic test. [2]

An assessment of the nails and joints is part of the initial examination. Nail changes increase the likelihood of associated psoriatic arthritis and alter monitoring strategies. Regular screening for arthritis symptoms using short questionnaires and thresholds for referral to a rheumatologist is recommended. [3]

Modern noninvasive imaging techniques improve accuracy in complex cases and allow for monitoring of response to therapy. Dermoscopy, optical coherence tomography, and reflectance confocal microscopy provide objective features that correlate with histology and are appropriate when clarification and biopsy-free observation are required. [4]

Table 1. Clinical clues: psoriasis versus “masked” dermatoses

Sign	Psoriasis	Atopic dermatitis	Seborrheic dermatitis	Dermatophytosis of the trunk
Plaque borders	Clear	More often blurred	Blurred at the periphery	Clear ring with a roller
scales	Dry, silvery	Less pronounced	Fatty, yellowish	There is a collar on the periphery
Typical localization	Elbows, knees, lower back, scalp	Bends in adults	Scalp, nasolabial folds	Isolated lesions on the trunk
Nails	Pitting, oil spots, subungual hyperkeratosis	Less often	There are no typical ones	Rarely
Trauma response	Koebner phenomenon	Maybe	Not typical	Not typical
Comment: The chart does not replace an examination; if in doubt, dermatoscopy and, if necessary, biopsy are indicated. [5]

Dermoscopy: What a Doctor "Sees" Without a Scalpel

Dermoscopy of plaque psoriasis reveals regularly distributed red pinpoint vessels on a light red background and diffuse white scales. These features, taken together, have high diagnostic value and allow one to differentiate psoriasis from eczematous and seborrheic lesions, where the vascular pattern and scale character are different. [6]

On the scalp, trichoscopy helps differentiate psoriasis from seborrheic dermatitis. Psoriasis is characterized by red spots and glomerular vessels, "hidden hair," and thicker white scales; seborrheic dermatitis is characterized by yellowish, greasy scales and a different vascular pattern. This is especially useful in cases of dense plaque and minimal skin visibility. [7]

Dermoscopy also detects hemorrhagic points and, occasionally, linear vessels, which is useful for monitoring the dynamics of inflammation during therapy. Monitoring changes in vascular patterns under the influence of treatment helps to objectively assess the response and promptly adjust the treatment regimen. [8]

In follicular psoriasis and atypical variants, the set of dermatoscopic signs is generally preserved, which facilitates the recognition of rare forms in the clinic. [9]

Table 2. Dermatoscopic signs of psoriasis and their differential value

Sign	Description	Diagnostic clue
Point vessels	A regular grid of red dots	Supports the diagnosis of plaque psoriasis
White diffuse scales	Small, dry	In favor of psoriasis, against seborrheic dermatitis
Glomerular vessels	Coiled capillary loops	More often with active inflammation
Hemorrhagic points	Pinpoint hemorrhages	Correlates with trauma and activity
"Hidden hair" on the head	Hair under dense scales	In favor of psoriasis when differentiating from seborrheic dermatitis
[10]

Lab tests: why are they needed if there is no “psoriasis test”?

There is no specific laboratory test that confirms psoriasis. These tests serve two purposes: to rule out "masking" symptoms and to assess comorbidities and the safety of future therapy. Routine inflammation tests are of little help in making a diagnosis, but are sometimes used to assess systemic activity. [11]

If guttate psoriasis is suspected, a search for streptococcal infection is warranted. Throat swabs for bacteriology and determination of antistreptolysin O and anti-DNase B titers are appropriate, especially in the first weeks after pharyngitis. This is not a "test for psoriasis," but it is an important clue to the streptococcal form. [12]

Before initiating systemic therapy, a complete blood count, liver and kidney function, lipid profile, glucose or glycated hemoglobin, viral hepatitis and human immunodeficiency virus infection status, and latent tuberculosis are typically assessed using immunoassays. The range and frequency of tests depend on the chosen treatment and local protocols. [13]

In cases of severe skin disease and the presence of risk factors, it is recommended to simultaneously assess cardiovascular and metabolic risks, as comorbidities influence outcomes and treatment choices. Regular screening is appropriate as early as the initial diagnosis. [14]

Table 3. Basic tests in the context of psoriasis: purpose of administration

Analysis	Why is it prescribed?	What does it affect?
Complete blood count	Exclude cytopenias, leukocyte level	Safety of systemic therapy
Liver biochemistry and creatinine	Assessment of organ function	Treatment selection and monitoring
Lipids, glucose, or glycated hemoglobin	Comorbidities, metabolic risk	Risk stratification and treatment goals
Tests for hepatitis and human immunodeficiency virus	Infection safety	Approvals for biological therapy
Immunotest for tuberculosis	Latent infection	Prevention of reactivation during therapy
[15]

Biopsy and histology: when and what signs to look for

A biopsy is indicated in cases of unclear clinical presentation, mixed variants, suspected cutaneous lymphoma, dermatophytosis with negative mycology, drug-induced rashes, and before aggressive therapy if the diagnosis is uncertain. It is important to biopsy an untreated area whenever possible, as topical steroids and emollients distort the picture. [16]

Classic histologic features include parakeratosis, absence of the granular layer, regular psoriasiform hyperplasia, thinning of the suprapapillary plates, dilated tortuous capillaries of the papillary dermis, Munro microabscesses, and spongiform pustules of Kogoy. The presence of a complete set in a single biopsy is not always observed, so the assessment is performed cumulatively. [17]

Some features overlap with other psoriasiform dermatoses, making both the distribution pattern of changes and the clinical-pathological correlation important. Contemporary reviews emphasize the importance of systematic slide reading and standardized descriptions to improve repeatability. [18]

In rare forms, such as generalized pustular, histology confirms a sterile neutrophilic infiltrate with pustule formation, which influences emergency care tactics and the choice of systemic treatment. [19]

Table 4. Key histological landmarks in psoriasis

Sign	The essence	Comment
Parakeratosis	Nucleated cells in the stratum corneum	Often associated with the absence of the granular layer
Psoriasiform hyperplasia	Regular elongation of epidermal processes	With thinning of the suprapapillary plates
Munro's microabscesses	Neutrophils in the stratum corneum	An important but not essential find
Kogoy's pustules	Neutrophils in the upper epidermis	More often with pustular variants
Dilated capillaries	Ecstatic meandering loops	Explains pinpoint hemorrhages during trauma
[20]

Non-invasive imaging: What the "eyes of the devices" add

Optical coherence tomography provides layered images of the epidermis and upper dermis, measuring epidermal thickness and visualizing vessels. Plaques exhibit increased epidermal thickness and signs of acanthosis; these parameters normalize with therapy, allowing for quantitative monitoring of the response. Linear scanning systems increase resolution, allowing for the recognition of details similar to histology. [21]

Reflectance confocal microscopy visualizes keratinocytes, the dermal-epidermal junction, and the superficial dermis in real time. A regular "honeycomb" pattern of the epidermis, dilated papillae with bright rings, and tortuous capillaries have been described in psoriasis; the method is useful for monitoring and reducing the number of diagnostic biopsies in complex areas. [22]

Comparative studies show that dermatoscopy remains more sensitive for initial diagnosis, while reflectance confocal microscopy improves accuracy in questionable pink plaques and helps determine the need for biopsy. The choice of instrument depends on the clinical task and availability. [23]

High-frequency ultrasound imaging of the skin reveals a hyperechoic superficial band and a subepidermal hypoechoic zone, which correlate with inflammation. This is a promising method for monitoring treatment response, especially in research studies. [24]

Table 5. Non-invasive instruments and their diagnostic “gain”

Method	What does it show?	When it is especially useful
Dermatoscopy	Vascular pattern and scales	Rapid confirmation of diagnosis, differentiation
Optical coherence tomography	Epidermal thickness, vascular network	Quantitative monitoring of response to therapy
Reflectance confocal microscopy	Cellular level, dermal papillae	Complex pink plaques, decreased biopsies
High-frequency ultrasound examination of the skin	Echostructures of inflammation	Research and dynamic observation
[25]

Nail psoriasis: how to evaluate it and why it affects treatment tactics

The nail plate often reveals the diagnosis: pitting, oil spots, subungual hyperkeratosis, and onycholysis are a classic feature. Dermoscopy confirmation increases the accuracy of diagnosis and helps differentiate it from onychomycosis. [26]

The NAPSI nail psoriasis severity index is used for standardization. Each nail is divided into quadrants, with separate assessments of the matrix and nail bed; the final score reflects the overall severity. Modified versions of the index are used in research and clinical practice, but it is important to understand their limitations and correctly interpret the dynamics. [27]

High nail index scores and persistent nail changes correlate with the risk of psoriatic arthritis. Therefore, in patients with significant nail involvement, regular arthritis questionnaires and a low threshold for referral to a rheumatologist are a practical strategy. [28]

Nail dermatoscopy and photographic recording simplify monitoring during therapy. Research is developing digital and algorithmic approaches to automatically assessing the nail psoriasis index, which promises more reproducible measurements. [29]

Table 6. NAPSI: How to read the nail psoriasis index

Component	What is taken into account	Range for one nail
Matrix	Pitting, leukonychia, red spots on the lunula, crumbling	0-4
Bed	Onycholysis, oil spots, subungual hyperkeratosis, hemorrhages	0-4
Result	Sum of matrix plus bed for 10 nails	0-80
[30]

Differential Diagnosis: Common Pitfalls and How to Avoid Them

Atopic dermatitis in adults on the extensor surfaces, seborrheic dermatitis on the scalp, pityriasis rosea, and dermatophytosis are common causes of confusion. Dermoscopy helps differentiate by the type of vessels and the nature of the scales; if a fungal origin is suspected, a mycological scraping is appropriate. A biopsy resolves controversial cases. [31]

The Auspitz sign and the Koebner phenomenon are not a "litmus test." They support the diagnosis in context, but they are also found in other dermatoses, so they are used only in conjunction with other data. [32]

Guttate pharyngitis often follows streptococcal pharyngitis. Focusing on questioning, pharyngeal examination, and targeted streptococcal testing allows for a timely diagnosis and a prognosis explanation. [33]

In pustular and erythrodermic forms, it is necessary to exclude other causes of generalized pustules and erythroderma, which sometimes makes biopsy and hospitalization necessary elements of safe diagnosis. [34]

Table 7. Indications for skin biopsy in suspected psoriasis

Situation	Cause
Atypical clinical presentation or unusual localization	Exclude psoriasiform and other dermatoses
Lack of effect from correct therapy with a confident clinical diagnosis	Reconsider the diagnosis
Before escalating systemic therapy in case of doubt	Confirm feasibility and safety
Childhood with a mixed picture	Minimize the risk of missing another pathology
[35]

Assessing severity and documenting baseline

The Psoriasis Area Severity Index (PASI), the Psoriasis Body Involvement Score, and quality-of-life indices such as the Dermatology Quality of Life Index are used for standardization. Severity thresholds have historically been based on the affected area: less than 3% is mild, 3-10% is moderate, and more than 10% is severe; however, involvement of "critical" areas can increase severity regardless of area. [36]

The "treat to target" approach offers a measurable goal of no more than 1% skin coverage by week 12 of therapy and maintenance of results at subsequent visits. This algorithm makes response assessment more transparent for both the patient and physician. [37]

It is useful for the clinic to photograph the initial plaques under standard lighting and record dermatoscopic findings. This facilitates objective comparison during subsequent visits and reduces the risk of subjective discrepancies. [38]

Given the multisystem nature of the disease, symptoms of possible arthritis, fatigue, impact on sleep and daily activity are assessed simultaneously, which influences the choice of therapy and patient routing. [39]

Table 8. Indices and thresholds applicable in the clinic

Tool	What does it measure?	Practical purpose
Psoriasis Area and Severity Index (PASI)	Intensity of features and area by zones	Basic severity stratification and dynamics
Area of body damage	Skin percentage according to the "palm rule"	Rapid assessment of severity and "critical zones"
Quality of life assessment	Impact on everyday life	Taking into account subjective severity and “treatment to target”
[40]

Screening for comorbidities and psoriatic arthritis

Patients with psoriasis have an increased risk of metabolic and cardiovascular disorders. Screening includes measurement of blood pressure, lipids, glucose, and lifestyle factors; the results are taken into account when choosing therapy and setting long-term goals. [41]

The presence of nail lesions, pain and morning stiffness in joints, and swelling of the fingers and back are all indicators of regular screening for psoriatic arthritis. The PEST questionnaire takes only minutes to complete; a threshold value indicates the need for a consultation with a rheumatologist. [42]

Further treatment for confirmed arthritis is developed in consultation with a rheumatologist based on current European guidelines, which describe the principles of drug therapy selection based on the phenotype of the lesion. The presence of arthritis changes the diagnostic and therapeutic approach for skin manifestations. [43]

Regular re-screening is appropriate even with a negative initial PEST, as arthritis may develop years after the onset of the skin process. This is a practical element of standard diagnostics at each visit. [44]

Table 9. Mini-checklist for screening comorbidities during primary diagnosis

Direction	What to check	How does it affect
Cardiovascular risk	Blood pressure, lipids, glucose, body weight	Choice of therapy and treatment-to-target goals
Psoriatic arthritis	PEST questionnaire, complaints and joint examination	Decision on referral to a rheumatologist
Psychological well-being	Impact on sleep, work, social contacts	Supportive measures and choice of therapy
Lifestyle factors	Smoking, alcohol, stress	Secondary prevention and prognosis
[45]

Step-by-step algorithm for examining a patient with suspected psoriasis

1. Anamnesis with a focus on onset, triggers, family history, itching, pain, and impact on quality of life. Examination of the skin, scalp, and nails with photography. [46]
2. Dermoscopy of the target plaques and, if necessary, trichoscopy. If there is any doubt about the fungal nature, mycology should be performed. [47]
3. In case of clinical uncertainty or atypia, skin biopsy of the untreated area with histology. [48]
4. Baseline tests to assess the safety of potential therapy and metabolic status.[49]
5. Screening for comorbidities and psoriatic arthritis, documentation of baseline severity and quality of life indices. [50]
6. If indicated, non-invasive imaging is used to clarify the diagnosis and for subsequent monitoring. [51]